icometrix provides imaging and data analytical services for clinical practice and drug development in neurology and radiology. The company develops digital, data-driven, integrated, and scalable real-world solutions to help patients, healthcare professionals, and pharmaceutical companies enter the era of personalized care for neurological disorders.

icometrix

icompanion

Transforming patient care through imaging AI.

Founded in 2011, icometrix (Leuven, Belgium; Boston, USA) strives for data-driven insights and personalized patient care, supported by artificial intelligence. icometrix offers a portfolio of AI solutions to assist healthcare with various challenges; icobrain extracts data from brain MRI and CT scans for the radiological reporting and clinical management of neurological disorders such as multiple sclerosis, brain trauma, epilepsy, stroke, dementia, and Alzheimer's disease. icompanion, a digital platform, and the mobile app helps people with MS and their care team to monitor clinical symptoms and treatments efficiently and objectively. icolung addresses the COVID-19 pandemic by measuring lung involvement on chest CT.
 
Today, icometrix is internationally active and integrated into more than 300 clinical practices. In addition, icometrix collaborates with healthcare providers and pharmaceutical companies on the evaluation of drug research for neurological disorders. 

NHS England

Michael J. Fox Foundation

Forestay Capital

Capricorn Partners

Optum Ventures

Are you attending #ENRS24 this week? 🧠 We are very excited to sponsor this wonderful event. Don't miss the opportunity to connect with Jan Verheyden and Kathy Hampton, at table #1. 💬 They are eager to meet you and share insights about how #icobrain is used as the standard of care for brain #MRI and #CT reporting in many hospitals across the US. 🏥 

👀  We also highly recommend attending Lawrence Tanenbaum's talk on the Validation of FLAIR lesion measurements on icobrain ms 5.14.

Feel free to contact Jan or Kathy to schedule an appointment. We look forward to seeing you there! 👋

Having a great time at #AAIC2024! 🧠 Day two is over and the conference is filled with valuable insights and exciting connections.

And we haven't left yet. Will you be attending #AAIC in the coming few days? Then come discover icobrain aria, our #AI-based software designed for automatic detection and quantification of ARIA-E and ARIA-H. We would be happy to discus on how we can support your clinical practice in treating people living with Alzheimer's disease.

Together, let's make a difference in the future of #Alzheimer's care! 🤝

I want to sincerely thank all the people who passed by our booth and with whom we met during the Alzheimer's Association® International Conference, #AAIC24 this week in Philadelphia. 

🧠 Thanks to all neurologists who are using or are eager to start using our #icobrain reports that support the (early/differential) diagnosis and treatment monitoring of #alzheimersdisease
🧠 Thanks to all patient advocacy groups and scientific societies for your important work and our great conversations. We have the same mission of improving the lives of individuals with Alzheimer's disease and, together with other biomarkers, the icometrix brain #MRI quantification and care coordination solutions are crucial for this.
🧠 Thanks to all scientists and researchers who are developing the next generation solutions that will impact patient care and who are validating the existing solutions and evidence. We can't wait to start all the research collaborations we discussed during the conference.
🧠 Thanks to all biotech and pharmaceutical representatives we met at #AAIC2024. Precision and personalized medicine aren't possible without the treatments you develop. Thanks for trusting the icometrix solutions and advanced imaging biomarkers to impact your clinical trials and real-world studies. 
🧠 Thanks to all people with Alzheimer's disease and their caregivers we had the opportunity to meet with. Your stories and experiences are touching, are essential input for our work, and are fueling us to push even harder to impact care.
🧠 Thanks to my wonderful colleagues Rebecca Bartz and Kathy Hampton for your passion, your drive, and your enthusiasm. ❤️

For a few years now, our slogan at icometrix has been
#BrainHealthMatters 🧠 Clever wordplay aside, this #WorldBrainDay, we want to talk about the growing burden of neurological disorders and the crucial role #medicaltechnology can play 👇 The increasing rate at which neurological disorders are occurring is alarming, affecting millions of lives and putting pressure on healthcare systems and professionals worldwide. Medical technology like #icobrain has proven to help reduce the burden on clinicians and support them in their jobs. However, a clear financial support system is essential, much like the CPT reimbursement code for icobrain in the US 🇺🇸 (read more via the link in comments). 

Introduced 8 months ago, these CPT codes for icobrain are already making an impact in the US 🇺🇸  #radiology field, enabling clinical sites to access state-of-the-art #icobrain technology that was previously out of reach, or allowing hospitals to roll out the software for all their patients instead of just a subset. The result? More patients receiving the world-class care they deserve.

The US reimbursement system, while complex, can serve as an example for the #EU, #Australia, #Canada, #Japan, and others. A unified European legislation could pave the way for more streamlined access to these vital technologies. By working together and advocating for these necessary changes, we can make a real difference in the lives of people living with neurological disorders. Let's continue to strive for a future where brain health is a priority for all. Together, we can make a difference.

🤝 Please repost so we can reach policy makers 🤝 or share your thoughts below!

#reimbursement #HealthPolicy #digitalhealth #neurology #worldbrainday #icobrain European Academy of Neurology American Academy of Neurology World Federation Of Neurology

The official website for the CLAIMS project is live! 💻

Icometrix is one of the 15 partners in the CLAIMS consortium and through our involvement in this EU-funded project, we aim to contribute to its mission of addressing the urgent need for a more data-driven approach 📈 and more personalised care for people with MS (pwMS). CLAIMS aims to realise this by developing, validating, and obtaining approval for a companion platform which will offer a holistic view of each patient, integrating both existing and cutting-edge biomarker data to predict disease progression under various treatment scenarios. 

If this triggered you, then head over to the CLAIMS website to discover more about the project, the people behind it, and it’s science and technology. 👨‍🔬 

🔗 https://www.claims.ms/ - Join us on this journey to transform MS care!

EAN is coming to an end! It was amazing to meet our partners and witness the rapidly changing landscape of neurology 🧠. We enjoyed insightful talks on #multiplesclerosis, #dementia, #NMO, #MOGAD, #parkinson and other neurological diseases and we are happy to contribute our own scientific work on the #MS topographical model and the relationship between NfL and imaging biomarkers in the #TREMEND trial.

It's not too late to meet us. If you are still in Helsinki, reach out to An Tanghe and Lars Costers to plan a meeting. 🇫🇮

ICOM

COM:ICOMETRIX

icometrix